Benchmark Investment Advisors LLC trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 12.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,915 shares of the semiconductor company’s stock after selling 414 shares during the quarter. Benchmark Investment Advisors LLC’s holdings in Synopsys were worth $1,415,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in SNPS. Kieckhefer Group LLC bought a new stake in shares of Synopsys in the fourth quarter worth about $27,000. Whipplewood Advisors LLC acquired a new position in shares of Synopsys in the 4th quarter valued at approximately $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in Synopsys during the 4th quarter worth approximately $34,000. Sierra Ocean LLC acquired a new stake in Synopsys during the 4th quarter worth approximately $39,000. Finally, Hazlett Burt & Watson Inc. lifted its stake in Synopsys by 28.6% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock valued at $44,000 after buying an additional 20 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Transactions at Synopsys
In other Synopsys news, insider Geus Aart De sold 15,705 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company’s stock, valued at $51,850,925.82. The trade was a 11.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the sale, the chief executive officer now owns 70,922 shares in the company, valued at $32,890,077.50. This represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 47,909 shares of company stock worth $22,794,835 in the last ninety days. Insiders own 0.62% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on SNPS
Synopsys Trading Down 7.1 %
NASDAQ:SNPS opened at $388.13 on Friday. The firm has a fifty day simple moving average of $473.83 and a 200 day simple moving average of $503.09. Synopsys, Inc. has a 1-year low of $387.41 and a 1-year high of $624.80. The stock has a market capitalization of $60.01 billion, a PE ratio of 26.73, a P/E/G ratio of 3.23 and a beta of 1.23.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Options Trading – Understanding Strike Price
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.